Skip to main content

Day: March 4, 2021

Micron Appoints Raj Hazra as Senior Vice President and General Manager of the Compute and Networking Business Unit

BOISE, Idaho, March 04, 2021 (GLOBE NEWSWIRE) — Micron Technology, Inc. (Nasdaq: MU), today announced the appointment of Raj Hazra to the role of senior vice president and general manager of Micron’s Compute and Networking Business Unit. Hazra succeeds Tom Eby, who plans to retire following more than a decade of leadership at Micron. Eby will serve as a senior advisor to the company during the interim and will remain with Micron through April. “Raj’s strong technical acumen and deep experience in data centers, make him an exceptional choice to lead our Compute and Networking Business Unit. I am excited to have Raj at the helm of our largest business as we seek to leverage opportunities in cloud, high-performance computing, artificial intelligence and client computing,” said Sumit Sadana, executive vice president and chief business...

Continue reading

GENFIT appoints Jean-François Tiné to the Board of Directors

 Lille, France; Cambridge, MA; March 04, 2021 – GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with metabolic and liver diseases, today announced the appointment of Jean-François Tiné as an independent board member.GENFIT’s Board of Directors has appointed Jean-François Tiné to replace Philippe Moons who resigned from his position as member of the Board.Jean-François Tiné will also join the Strategy and Alliances Committee and Eric Baclet will become a member of the Audit Committee.Jean-François Tiné is a seasoned senior investment banking executive.In 2017, he was appointed Chairman of Equity Capital Markets at Natixis Corporate & Investment Banking after joining Natixis in 2005 as Global Head of Equity Capital Markets.He began his career in various sales,...

Continue reading

GENFIT : Jean-François Tiné rejoint le Conseil d’Administration

Lille (France), Cambridge (Massachusetts, États-Unis), le 4 mars 2021 – GENFIT (Nasdaq et Euronext: GNFT), société biopharmaceutique de phase avancée engagée dans l’amélioration de la vie des patients atteints de maladies hépatiques et métaboliques, annonce aujourd’hui la cooptation de Monsieur Jean-François Tiné en qualité d’administrateur indépendant.Le Conseil d’Administration de GENFIT a décidé de coopter Monsieur Jean-François Tiné en remplacement de Monsieur Philippe Moons qui a démissionné de ses fonctions.Monsieur Jean-François Tiné intègrera le Comité Stratégie et Alliances et monsieur Eric Baclet le Comité d’Audit.Monsieur Jean-François Tiné est un cadre dirigeant aguerri de la banque d’investissement.Il a notamment occupé la fonction de chairman du marché primaire actions au sein de la banque de grande clientèle de Natixis, poste...

Continue reading

ATEC Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Corporate Highlights

U.S. Revenue Grows 38% in Fourth Quarter and 30% for Full YearRevenue Growth Averages ~30% Over Past Eight QuartersCARLSBAD, Calif., March 04, 2021 (GLOBE NEWSWIRE) — Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter and year ended December 31, 2020, and recent corporate highlights.Fourth Quarter and Full Year 2020 Financial ResultsRecent HighlightsExpanded contribution from new products to 75% of Q4 U.S. revenue, up from 48% in Q4 2019;Increased Q4 average U.S. revenue per case by 13% year-over-year, driven by continued strong performance from AlphaInformatiX and lateral interbody fusion (LIF), which includes Prone TransPsoas (PTP™);Continued sales network transformation, resulting in 47% year-over-year...

Continue reading

Opiant Pharmaceuticals Reports Fourth Quarter and Full-Year 2020 Financial Results and Provides Corporate Update

SANTA MONICA, Calif., March 04, 2021 (GLOBE NEWSWIRE) — Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines to treat addictions and drug overdose, today reported financial results for the fourth quarter and year ended December 31, 2020 and provided a corporate update. Pipeline UpdateContinue to advance OPNT003, nasal nalmefene, for opioid overdose, with significant clinical and regulatory milestones expected in 2021Confirmatory pharmacokinetic (“PK”) studyAnticipate full enrollment April 2021Top-line data anticipated in June 2021Pharmacodynamic (“PD”) studyProtocol filed with U.S. Food and Drug Administration (“FDA”)Received Institutional Review Board (“IRB”) approval to initiate trialAnticipate commencing patient dosing mid-March 2021Top-line data expected by the start...

Continue reading

The Joint Corp. Reports Fourth Quarter and Full Year 2020 Financial Results

– Grows Revenue 23% Quarterly and 21% Annually, Compared to 2019 –– Reports Record Annual Operating Income of $5.5 Million, Up 61% Compared to 2019 –– Posts Record Adjusted EBITDA of $9.1 Million, Up 47% Compared to 2019 –– Increases Total Clinic Count to 579, Opening 21 Clinics in Q4 2020, Compared to 25 in Q4 2019 –– Sells Record 56 Franchise Licenses in Q4 2020, Up from 23 in Q4 2019 –SCOTTSDALE, Ariz., March 04, 2021 (GLOBE NEWSWIRE) — The Joint Corp. (NASDAQ: JYNT), a national operator, manager and franchisor of chiropractic clinics, reported its financial results for the quarter and full year ended December 31, 2020.Financial Highlights: Q4 2020 Compared to Q4 2019Increased system-wide sales1 by 24%, to $77.6 million.Reported system-wide comp sales2 increase of 16%.Grew...

Continue reading

Franchise Group, Inc. to Announce Fourth Quarter and Full Year 2020 Earnings on March 10, 2021 and Participation in Upcoming Investor Conferences

ORLANDO, Fla., March 04, 2021 (GLOBE NEWSWIRE) — Franchise Group, Inc. (NASDAQ: FRG) (“Franchise Group” or the “Company”) today announced it will release its fourth quarter and full year 2020 financial results on March 10, 2021. Franchise Group will conduct a conference call on March 10th at 4:30 P.M. ET to discuss its business, financial results and provide its preliminary outlook for 2021.A real-time webcast of the conference call will be available on the Events page of Franchise Group’s website at www.franchisegrp.com. The conference call can also be accessed live via telephone at (877) 784-1793. The passcode is 2193847. Please dial in 5-10 minutes prior to the scheduled start time.Franchise Group will virtually participate in the UBS Global Consumer and Retail Virtual Conference on March 9, 2021 and the D.A. Davidson 4th Annual...

Continue reading

Chuy’s Holdings, Inc. Announces Fourth Quarter and Fiscal Year 2020 Financial Results

AUSTIN, Texas, March 04, 2021 (GLOBE NEWSWIRE) — Chuy’s Holdings, Inc. (NASDAQ:CHUY) today announced financial results for the 13-week and 52-week periods ended December 27, 2020.Selected monthly comparable restaurant sales and average weekly sales per restaurant for the fourth quarter and the first quarter of 2021 to-date are as follows:Comparable restaurant sales were negatively impacted by closures of dining rooms in Kentucky, Colorado and Illinois during the latter part of November and December due to the COVID-19 pandemic as well as reduced traffic during the Thanksgiving week and on Christmas Day which fell on Friday, a higher volume day, as compared to Wednesday last year. Off-premise sales remained strong at a rate more than double pre-COVID-19 levels ranging from 30% to 35% of all revenue during the fourth quarter and the...

Continue reading

Oaktree Strategic Income Corporation Announces Record Date for Special Dividend

LOS ANGELES, CA, March 04, 2021 (GLOBE NEWSWIRE) — Oaktree Strategic Income Corporation (NASDAQ:OCSI) (“Oaktree Strategic Income” or the “Company”) today announced that the record date for its special dividend will be March 17, 2021. This special dividend will be in an amount equal to all of the Company’s undistributed net ordinary income and capital gains through the closing date of the proposed two-step merger (the “Merger”) of the Company with and into Oaktree Specialty Lending Corporation (“OCSL”). The Company currently estimates that the amount of the special dividend will be between $0.10 and $0.14 per share assuming that the Merger closes prior to March 31, 2021. The actual amount of the special dividend may be more or less than the estimated amount and will be determined by the Company’s Board of Directors prior to the closing...

Continue reading

Wrap Reports Fourth Quarter 2020 Results

TEMPE, Ariz., March 04, 2021 (GLOBE NEWSWIRE) — Wrap Technologies, Inc. (Nasdaq: WRAP) (the “Company”), a global leader in innovative public safety technologies and services, today announced results for its fourth quarter and fiscal year ended December 31, 2020.Fourth Quarter 2020 SummaryNet Sales of $1.4 million, Growth of 464%Gross Margin of 33%Cash, Cash Equivalents and Short-Term Investments of $41.6 millionStock Symbol Changed to: WRAPFull Year 2020 SummaryNet Sales of $3.9 million, Growth of 466%Gross Margin of 34%Sold Product to 15 New Countries – 36 Countries to DateTrained Agencies Increased to Over 450 AgenciesBolaWrap Certified Instructors Increased to 1,360Management Commentary – Tom Smith, President“As public safety experienced historic challenges in 2020, WRAP adapted to a quickly-evolving market by putting increased...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.